Products for Research Use Only

Cefotaxime

CAT: 0804-HY-A0088A-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-A0088A-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cefotaxime, a β-lactamase stable cephalosporin and a third-generation cephalosporin antibiotic, possesses broad-spectrum antibiotic activity against numerous Gram-positive and Gram-negative bacteria[1][2][3][4][2].
CAS Number
63527-52-6
Product Name Alternative
Cefotaxim; HR-756
UNSPSC
12352005
Hazard Statement
H317, H334
Target
Antibiotic; Bacterial; Beta-lactamase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cefotaxime.html
Concentration
10mM
Purity
99.06
Solubility
DMSO : 250 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL
Smiles
O=C(C(N12)=C(COC(C)=O)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)O
Molecular Formula
C16H17N5O7S2
Molecular Weight
455.47
Precautions
H317, H334
References & Citations
[1]Hee-Chang Jang, et al. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis. PLoS One. 2014 Jun 30;9 (6) :e101118.|[2]Woodfield JC, et al. A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. Am J Surg. 2003 Jan;185 (1) :45-9.|[3]Scholz H, et al. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Chemotherapy. 1998 Mar-Apr;44 (2) :142-7.|[4]Gums JG, et al. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies. Ann Pharmacother. 2008 Jan;42 (1) :71-9.|[5]E L Francke, et al. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms. Am J Med. 1981 Sep;71 (3) :435-42.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
β-lactam
Citation 01
ACS Environ Au. 2025 Aug 8.|AMB Express. 2024 Dec 24;14 (1) :141.|Anal Chem. 2025 Jun 3;97 (21) :11099-11109.|bioRxiv. 2024 May 10.|Cell. 2025 Mar 6;188 (5) :1330-1348.e27.|Int J Antimicrob Agents. 2025 Jun 9:107551.|J Antibiot (Tokyo) . 2025 Mar;78 (4) :265-273.|Molecules. 2025 Mar 9;30 (6) :1224.|Biomed Chromatogr. 2024 Jul 8:e5955.|Chin J Traumatol. 2024 Jul 3:S1008-1275 (24) 00075-0.